MX2014008390A - Formulaciones de romidepsina y sus usos. - Google Patents
Formulaciones de romidepsina y sus usos.Info
- Publication number
- MX2014008390A MX2014008390A MX2014008390A MX2014008390A MX2014008390A MX 2014008390 A MX2014008390 A MX 2014008390A MX 2014008390 A MX2014008390 A MX 2014008390A MX 2014008390 A MX2014008390 A MX 2014008390A MX 2014008390 A MX2014008390 A MX 2014008390A
- Authority
- MX
- Mexico
- Prior art keywords
- romidepsin
- formulations
- romidepsin formulations
- mannitol
- formulation
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- OHRURASPPZQGQM-GCCNXGTGSA-N romidepsin Chemical compound O1C(=O)[C@H](C(C)C)NC(=O)C(=C/C)/NC(=O)[C@H]2CSSCC\C=C\[C@@H]1CC(=O)N[C@H](C(C)C)C(=O)N2 OHRURASPPZQGQM-GCCNXGTGSA-N 0.000 title abstract 3
- 229960003452 romidepsin Drugs 0.000 title abstract 3
- OHRURASPPZQGQM-UHFFFAOYSA-N romidepsin Natural products O1C(=O)C(C(C)C)NC(=O)C(=CC)NC(=O)C2CSSCCC=CC1CC(=O)NC(C(C)C)C(=O)N2 OHRURASPPZQGQM-UHFFFAOYSA-N 0.000 title abstract 3
- 108010091666 romidepsin Proteins 0.000 title abstract 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/15—Depsipeptides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261586066P | 2012-01-12 | 2012-01-12 | |
| PCT/US2013/021212 WO2013106696A1 (en) | 2012-01-12 | 2013-01-11 | Romidepsin formulations and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2014008390A true MX2014008390A (es) | 2014-09-22 |
Family
ID=47604232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014008390A MX2014008390A (es) | 2012-01-12 | 2013-01-11 | Formulaciones de romidepsina y sus usos. |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20130184225A1 (enExample) |
| EP (1) | EP2802340B1 (enExample) |
| JP (1) | JP6170946B2 (enExample) |
| CN (1) | CN104168908A (enExample) |
| AU (1) | AU2013201937B8 (enExample) |
| CA (1) | CA2863291A1 (enExample) |
| MX (1) | MX2014008390A (enExample) |
| WO (1) | WO2013106696A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ630311A (en) * | 2013-12-27 | 2016-03-31 | Celgene Corp | Romidepsin formulations and uses thereof |
| CN106137980B (zh) * | 2015-03-31 | 2021-04-13 | 深圳翰宇药业股份有限公司 | 一种罗米地辛脂微球制剂及其制备方法 |
| JP6980534B2 (ja) | 2015-06-25 | 2021-12-15 | ザ チルドレンズ メディカル センター コーポレーション | 造血幹細胞の増大、富化、および維持に関する方法および組成物 |
| WO2017161001A1 (en) | 2016-03-15 | 2017-09-21 | Children's Medical Center Corporation | Methods and compositions relating to hematopoietic stem cell expansion |
| US20210169871A1 (en) * | 2018-04-05 | 2021-06-10 | Tarveda Therapeutics, Inc. | Pharmaceutical compositions with reduced tert-butanol levels |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8817743D0 (en) | 1988-07-26 | 1988-09-01 | Fujisawa Pharmaceutical Co | Fr901228 substance & preparation thereof |
| JPH0764872A (ja) | 1993-08-26 | 1995-03-10 | Fujitsu Ten Ltd | データ記憶制御装置 |
| US20070148228A1 (en) * | 1999-02-22 | 2007-06-28 | Merrion Research I Limited | Solid oral dosage form containing an enhancer |
| ATE294571T1 (de) * | 1999-03-03 | 2005-05-15 | Lilly Co Eli | Echinocandin pharmazeutische zusammensetzungen |
| US7396665B2 (en) | 2000-09-01 | 2008-07-08 | Astellas Pharma, Inc. | Method of producing FR901228 |
| EP1638541B1 (en) * | 2003-06-27 | 2010-05-19 | Astellas Pharma Inc. | Therapeutic agent for soft tissue sarcoma |
| GB0511266D0 (en) | 2005-06-02 | 2005-07-13 | Trust | Chemical compounds |
| WO2007146234A2 (en) * | 2006-06-09 | 2007-12-21 | Merrion Research Ii Limited | Solid oral dosage form containing an enhancer |
| CN103497238A (zh) * | 2006-12-29 | 2014-01-08 | 细胞基因公司 | 制备Romidepsin |
| WO2008127659A2 (en) * | 2007-04-13 | 2008-10-23 | University Of Texas Southwestern Medical Center | Combination therapy for cancer |
| JP2010105965A (ja) * | 2008-10-30 | 2010-05-13 | Taiyo Yakuhin Kogyo Kk | バンコマイシン製剤 |
| CA2781666C (en) * | 2009-11-23 | 2017-02-21 | Cubist Pharmaceuticals, Inc. | Lipopeptide compositions and related methods |
| CN103108648A (zh) | 2010-07-12 | 2013-05-15 | 细胞基因公司 | 罗米地辛固体形式及其用途 |
-
2013
- 2013-01-11 AU AU2013201937A patent/AU2013201937B8/en not_active Ceased
- 2013-01-11 CN CN201380013811.9A patent/CN104168908A/zh active Pending
- 2013-01-11 WO PCT/US2013/021212 patent/WO2013106696A1/en not_active Ceased
- 2013-01-11 US US13/740,063 patent/US20130184225A1/en not_active Abandoned
- 2013-01-11 JP JP2014552325A patent/JP6170946B2/ja active Active
- 2013-01-11 EP EP13701320.7A patent/EP2802340B1/en active Active
- 2013-01-11 CA CA2863291A patent/CA2863291A1/en not_active Abandoned
- 2013-01-11 MX MX2014008390A patent/MX2014008390A/es unknown
-
2014
- 2014-10-17 US US14/517,716 patent/US20150051157A1/en not_active Abandoned
-
2016
- 2016-09-06 US US15/257,771 patent/US20160367625A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20160367625A1 (en) | 2016-12-22 |
| WO2013106696A1 (en) | 2013-07-18 |
| EP2802340B1 (en) | 2020-10-28 |
| JP2015503623A (ja) | 2015-02-02 |
| AU2013201937B2 (en) | 2015-07-30 |
| AU2013201937A1 (en) | 2013-08-01 |
| CN104168908A (zh) | 2014-11-26 |
| US20150051157A1 (en) | 2015-02-19 |
| EP2802340A1 (en) | 2014-11-19 |
| AU2013201937B8 (en) | 2015-08-20 |
| JP6170946B2 (ja) | 2017-07-26 |
| US20130184225A1 (en) | 2013-07-18 |
| AU2013201937A8 (en) | 2015-08-20 |
| CA2863291A1 (en) | 2013-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12014501844B1 (en) | Peptidomimetic macrocycles | |
| TN2012000414A1 (en) | Forms of rifaximin and uses thereof | |
| TR201813877T4 (tr) | Spi̇nal müsküler atrofi̇ni̇n tedavi̇ edi̇lmesi̇ne yöneli̇k bi̇leşi̇kler. | |
| MY169141A (en) | Biodegradable compositions, methods and uses thereof | |
| AR125920A2 (es) | Composiciones que comprenden vortioxetina y donepezil | |
| JO3755B1 (ar) | تركيبات تستوستيرون | |
| MX2016008448A (es) | Conjugados de var2csa-farmaco. | |
| CA150044S (en) | Air freshener refill | |
| AU2013225816A8 (en) | Compositions and methods for treating Type III Gaucher Disease | |
| EP3038611A4 (en) | Novel 2,4-dinitrophenol formulations and methods using same | |
| AU342850S (en) | Multifaceted gemstone design | |
| SG11201507608PA (en) | Toxoid, compositions and related methods | |
| AU342848S (en) | Multifaceted gemstone design | |
| AU342852S (en) | Multifaceted gemstone design | |
| MX367393B (es) | Composiciones antifungicas para el tratamiento de piel y uñas. | |
| MX356727B (es) | Formulaciones de liberacion modificada de viloxacina. | |
| BR112013000930A2 (pt) | formulações de 14-epi-análogos de vitamina d e cmc | |
| SG11201507578PA (en) | Toxoid, compositions and related methods | |
| GB201208409D0 (en) | Vesicular formulations, kits and uses | |
| GB201208384D0 (en) | Vesicular formulations, uses and methods | |
| MX2013008559A (es) | Derivados de leptina. | |
| CA139212S (en) | Air sanitizing device | |
| PL2852385T3 (pl) | Dronedaron do zastosowania w leiszmaniozie, formulacje i połączenia do stosowania w leiszmaniozie | |
| WO2014022669A3 (en) | Antiperspirant compositions and methods | |
| UA90689U (uk) | Комплексний протипаразитарний препарат "лактоверм" |